Does Rallies show Form 4 insider transactions for SBC?

Yes. Rallies tracks SBC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SBC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SBC. It does not provide personalized investment advice.

SBC (SBC Medical Group Holdings Incorporated Common Stock) Stock Analysis - Insider Trades

SBC Medical Group Holdings Incorporated Common Stock (SBC) is a publicly traded Industrials sector company. As of May 20, 2026, SBC trades at $3.07 with a market cap of $294.40M and a P/E ratio of 7.19. SBC moved +4.15% today. Year to date, SBC is -33.26%; over the trailing twelve months it is -15.25%. Its 52-week range spans $2.62 to $10.25. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces SBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SBC stock inside the company?

Recent SBC insider activity includes Aikawa Yoshiyuki sold 465.00K, Aikawa Yoshiyuki sold 3.10M, Aikawa Yoshiyuki sold 4.42M, and ZUU Co. Ltd. bought 6.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SBC Key Metrics

Key financial metrics for SBC
Metric	Value
Price	$3.07
Market Cap	$294.40M
P/E Ratio	7.19
EPS	$0.40
Dividend Yield	0.43%
52-Week High	$10.25
52-Week Low	$2.62
Volume	112.61K
Avg Volume	0
Revenue (TTM)	$169.34M
Net Income	$40.88M
Gross Margin	70.80%

Recent SBC Insider Trades

Aikawa Yoshiyuki sold 465.00K (~$1.41M) on Apr 28, 2026.
Aikawa Yoshiyuki sold 3.10M (~$9.37M) on Apr 21, 2026.
Aikawa Yoshiyuki sold 4.42M (~$9.38M) on Mar 6, 2026.
ZUU Co. Ltd. bought 6.20K (~$45.48K) on Sep 19, 2024.

Latest SBC News

SBC Medical Group Upgraded to Buy with $10 Price Target after 9% Q1 Growth — May 20, 2026
SBC Medical Group Q1 Revenue Drops 9% to $43M; EBITDA Soars 117% — May 14, 2026
SBC Medical Group’s Buy-Extended Rating Stands with $9.00 Price Target — Apr 22, 2026
SBC Medical Group’s Q4 Revenue Drops to $39.6M; Analyst Holds $9 Target — Apr 6, 2026
SBC Medical Names AI Veteran as CTO to Drive Scalable Infrastructure — Mar 2, 2026

SBC Analyst Consensus

2 analysts cover SBC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.

Common questions about SBC

Who is trading SBC stock inside the company?: Recent SBC insider activity includes Aikawa Yoshiyuki sold 465.00K, Aikawa Yoshiyuki sold 3.10M, Aikawa Yoshiyuki sold 4.42M, and ZUU Co. Ltd. bought 6.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SBC?: Yes. Rallies tracks SBC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SBC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SBC. It does not provide personalized investment advice.